Cantitate/Preț
Produs
Total produse
Vezi coșul
Angiogenesis: An Integrative Approach from Science to Medicine de William D. Figg

Angiogenesis: An Integrative Approach from Science to Medicine

Editat de William D. Figg, Judah Folkman
en Limba Engleză Paperback – 25 noi 2014
Dr. Judah Folkman is considered the "father of angiogenesis." Because of Folkman's discovery and research, the possibilities of angiogenic therapy have broadened beyond cancer to many noncancerous diseases. Angiogenesis: An Integrative Approach from Science to Medicine is a comprehensive, concise summary of tumor angiogenesis. It is an up-to-date and authoritative reference for the angiogenesis field as it relates to oncology. This book represents the first collection in a volume of which Folkman is co-editor. Folkman has authored nearly 400 original papers and more than 100 book chapters.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 141922 lei  43-57 zile
  Springer Us – 25 noi 2014 141922 lei  43-57 zile
Hardback (1) 136916 lei  38-44 zile
  Springer Us – iun 2008 136916 lei  38-44 zile

Preț: 141922 lei

Preț vechi: 149392 lei
-5% Nou

Puncte Express: 2129
Preț estimativ în valută:
27157€ • 28680$ • 225100£

Carte tipărită la comandă

Livrare economică 13-27 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781489996688
ISBN-10: 1489996680
Pagini: 624
Ilustrații: XIX, 601 p.
Dimensiuni: 210 x 279 x 33 mm
Greutate: 1.38 kg
Ediția:2008
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States

Public țintă

Research

Descriere

Dr. Judah Folkman, “father of angiogenesis”, (1933-2008) was the Director of the Vascular Biology Program, Andrus Professor of Pediatric Surgery, and Professor of Cell Biology at Harvard University's Boston Children's Hospital. In the 1971 issue of The New England Journal of Medicine, he proposed the theory that tumor growth is angiogenesis dependent. This premise was the basis of this field of research and has become the focus of scientists worldwide. Because of Folkman's discovery and research, the possibilities of antiangiogenic and angiogenic therapy have broadened beyond cancer to many noncancerous diseases.
This book represents the first collection in a volume of which Dr. Folkman is co-editor. Dr. Folkman authored nearly 400 original papers and more than 100 book chapters.
Dr. William Figg is the chief of the Molecular and Clinical Pharmacology Program at the National Cancer Institute, National Institutes of Health. Over the past 15 years, his laboratory and clinic at the NCI have focused on the development of angiogenesis inhibitors. Dr. Figg has published more than 380 publications.

Cuprins

History of Angiogenesis.- Angiogenesis and Vascular Remodeling: Biology and Architecture of the Vasculature.- Endothelial Cell Activation.- Pericytes, the Mural Cells of the Microvascular System.- Matrix Metalloproteinases and Their Endogenous Inhibitors.- Integrins in Angiogenesis.- Fibroblast Growth Factor-2.- Vascular Permeability Factor/Vascular Endothelial Growth Factor.- Platelet-derived Growth Factor.- Angiopoietins and Tie Receptors.- Basement Membrane-derived Inhibitors of Angiogenesis.- Endostatin and Angiostatin.- Thrombospondins.- Overview of Angiogenesis during Tumor Growth.- Hypoxic Regulation of Angiogenesis by HIF-1.- Regulation of Angiogenesis by von Hippel Lindau Protein and HIF2.- Nitric Oxide in Tumor Angiogenesis.- VEGF Signal Transduction in Angiogenesis.- Delta-like Ligand 4/Notch Pathway in Tumor Angiogenesis.- Immune Cells and Inflammatory Mediators as Regulators of Angiogenesis.- Contribution of Endothelial Progenitor Cells to the Angiogenic Process.- The Cancer Stem Cell Model.- Targeting the Tumor Microenvironment (Stroma).- Normalization of Tumor Vasculature and Microenvironment.- Targeted Drug Delivery to the Tumor Neovasculature.- Models for Angiogenesis.- Surrogates for Clinical Development.- Imaging of Angiogenesis.- Tumor Endothelial Markers.- Overview and Clinical Applications of VEGF-A.- Protein Tyrosine Kinase as Antiangiogenic Agents.- Therapeutic Strategies that Target the HIF System.- The Clinical Utility of Bevacizumab.- Development of Thalidomide and its IMiD Derivatives.- TNP-470: The Resurrection of One of the First Angiogenesis Inhibitors.- Clinical Development of VEGF Trap.- Recent Advances in Angiogenesis Drug Development.- Combination of Angiogenic Therapy with other Anticancer Therapies.- Immunotherapy of Angiogenesis with DNA Vaccines.- Challenges of Antiangiogenic Therapy of Tumors.- Pharmacogenetics of Antiangiogenic Therapy.- Angiogenesis in the Central Nervous System.-Lymphatic Vascular System and Lymphangiogenesis.- Ocular Neovascularization.- Angiogenesis and Pathology in the Oral Cavity.- Revascularization of Wound: The Oxygen-Hypoxia Paradox.- Journeys in Coronary Angiogenesis.- Perspectives on the Future of Angiogenesis Research.

Recenzii

From the reviews:
"Folkman ... assembled his final masterpiece in Angiogenesis, a book he coedited with William Figg. ... The text, written by well-known contributors to the field, is complemented by a large number of helpful schematics and photomicrographs. The references are extensive and encyclopedic. In summary, if I were to have a single textbook on this subject on my bookshelf, this book would have no competition. ... this will be the authoritative text on angiogenesis for many years to come." (Douglas W. Losordo, New England Journal of Medicine, Vol. 359 (23), December, 2008)

Caracteristici

A comprehensive, concise summary of tumor angiogenesis
An up-to-date and authoritative reference for the angiogenesis field as it relates to oncology
Includes supplementary material: sn.pub/extras